
TY  - JOUR
TI  - Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma
JO  - Hepatology
JA  - Hepatology
VL  - 62
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28212
DO  - doi:10.1002/hep.28212
SP  - 380A
EP  - 456A
PY  - 2015
ER  - 

TY  - JOUR
AU  - Editorial Board
TI  - Abstracts - SSIEM 42st Annual Symposium, Paris, France, 6-9 September, 2005
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 28
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1007/s10545-004-0001-x
DO  - doi:10.1007/s10545-004-0001-x
SP  - 1
EP  - 262
PY  - 2005
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15405
DO  - doi:10.1111/ajt.15405
SP  - 310
EP  - 590
PY  - 2019
ER  - 

TY  - JOUR
TI  - ABSTRACTS FOR INVITED PRESENTATIONS
JO  - Artificial Organs
VL  - 21
IS  - 6
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1997.tb00507.x
DO  - doi:10.1111/j.1525-1594.1997.tb00507.x
SP  - 473
EP  - 577
PY  - 1997
ER  - 

TY  - JOUR
AU  - Padmanabhan, Anand
AU  - Connelly-Smith, Laura
AU  - Aqui, Nicole
AU  - Balogun, Rasheed A.
AU  - Klingel, Reinhard
AU  - Meyer, Erin
AU  - Pham, Huy P.
AU  - Schneiderman, Jennifer
AU  - Witt, Volker
AU  - Wu, Yanyun
AU  - Zantek, Nicole D.
AU  - Dunbar, Nancy M.
AU  - Schwartz, Guest Editor: Joseph
TI  - Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
JO  - Journal of Clinical Apheresis
JA  - J Clin Apher
VL  - 34
IS  - 3
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.21705
DO  - doi:10.1002/jca.21705
SP  - 171
EP  - 354
PY  - 2019
AB  - ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** Ninety-fourth Annual Meeting, The Hilton Hawaiian Village Honolulu, Hawaii, March 24–26, 1993
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 53
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1038/clpt.1993.20
DO  - doi:10.1038/clpt.1993.20
SP  - 135
EP  - 241
PY  - 1993
AB  - Clinical Pharmacology and Therapeutics (1993) 53, 135?241; doi:10.1038/clpt.1993.20
ER  - 

TY  - JOUR
TI  - 43rd Congress of the International Society of Paediatric Oncology (SIOP) 2011 Auckland, New Zealand, 28th–30th October, 2011, SIOP Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 57
IS  - 5
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.23299
DO  - doi:10.1002/pbc.23299
SP  - 705
EP  - 897
PY  - 2011
ER  - 

TY  - JOUR
TI  - AUSTRALIAN SOCIETY FOR GERIATRIC MEDICINE
JO  - Australian and New Zealand Journal of Medicine
VL  - 26
IS  - 4
SN  - 0004-8291
UR  - https://doi.org/10.1111/j.1445-5994.1996.tb00619.x
DO  - doi:10.1111/j.1445-5994.1996.tb00619.x
SP  - 585
EP  - 599
PY  - 1996
ER  - 

AU  - Westman, E. L.
AU  - Matewish, J. M.
AU  - Lam, J. S.
C7  - pp. 443-468
TI  - Pseudomonas
SN  - 9780813812373
UR  - https://doi.org/10.1002/9780470958209.ch23
DO  - doi:10.1002/9780470958209.ch23
SP  - 443-468
KW  - Pseudomonas
KW  - Pseudomonas species - remarkable nutritional diversity
KW  - Pseudomonas aeruginosa - opportunistic pathogen
KW  - division of pathogenesis of P. aeruginosa infections - bacterial colonization, multiplication, systemic disease
KW  - host immune defense mechanisms - exerting bactericidal effects
KW  - Pilus-deficient strains - causing epithelial cell damage
PY  - 1996
AB  - Summary This chapter contains sections titled: Introduction Overview of Pathogenesis Virulence Factors of Pseudomonas aeruginosa Antibiotic Resistance Impact of Whole Genome Sequences Vaccines Conclusions and Future Prospects References
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1440-1797.2005.00421.x
DO  - doi:10.1111/j.1440-1797.2005.00421.x
SP  - A233
EP  - A342
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstract
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 22
IS  - S2
SN  - 9780813812373
UR  - https://doi.org/10.1111/1756-185X.13533
DO  - doi:10.1111/1756-185X.13533
SP  - 16
EP  - 42
PY  - 2019
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - Australian and New Zealand Journal of Obstetrics and Gynaecology
JA  - Aust N Z J Obstet Gynaecol
VL  - 59
IS  - S1
SN  - 9780813812373
UR  - https://doi.org/10.1111/ajo.13067
DO  - doi:10.1111/ajo.13067
SP  - 11
EP  - 82
PY  - 2019
ER  - 

TY  - JOUR
TI  - RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 33
IS  - 2
SN  - 9780813812373
UR  - https://doi.org/10.1111/jvim.15372
DO  - doi:10.1111/jvim.15372
SP  - 1015
EP  - 1101
PY  - 2019
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
VL  - 42
IS  - s1
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1365-2362.2012.02650.x
DO  - doi:10.1111/j.1365-2362.2012.02650.x
SP  - 12
EP  - 88
PY  - 2012
ER  - 

TY  - JOUR
TI  - American association of anatomists. Seventy-fourth annual session; the University of Illinois college of medicine, March 21, 22, 23, 24, 1961. Officers, abstracts, demonstrations
JO  - The Anatomical Record
JA  - Anat. Rec.
VL  - 139
IS  - 2
SN  - 9780813812373
UR  - https://doi.org/10.1002/ar.1091390211
DO  - doi:10.1002/ar.1091390211
SP  - 201
EP  - 344
PY  - 1961
ER  - 

TY  - JOUR
TI  - Abstracts of the 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 16
IS  - S2
SN  - 9780813812373
UR  - https://doi.org/10.1002/pds.1461
DO  - doi:10.1002/pds.1461
SP  - S1
EP  - S274
PY  - 2007
ER  - 

TY  - JOUR
AU  - PATERSON, PHILIP Y.
AU  - Day, Eugene D.
AU  - Whitacre, Caroline C.
TI  - Neuroimmunologic Diseases: Effector Cell Responses and Immunoregulatory Mechanisms
JO  - Immunological Reviews
VL  - 55
IS  - 1
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1600-065X.1981.tb00340.x
DO  - doi:10.1111/j.1600-065X.1981.tb00340.x
SP  - 89
EP  - 120
PY  - 1981
ER  - 

AU  - Stine Jr, W. Blaine
AU  - LaDu, Mary Jo
C7  - pp. 211-243
TI  - Apolipoprotein E: Structural and Functional Interactions with Amyloid β
SN  - 9783527310722
UR  - https://doi.org/10.1002/9783527619344.ch10
DO  - doi:10.1002/9783527619344.ch10
SP  - 211-243
KW  - apolipoprotein E
KW  - genetics
KW  - oligomers
KW  - plasma
KW  - receptors
PY  - 1981
AB  - Summary This chapter contains sections titled: Introduction ApoE Background ApoE and A ? Other A ? Binding Proteins
ER  - 

TY  - JOUR
TI  - Cell biochemistry
JO  - European Journal of Biochemistry
VL  - 271
IS  - s1
SN  - 9783527310722
UR  - https://doi.org/10.1111/j.1474-3833.2004.4121.x
DO  - doi:10.1111/j.1474-3833.2004.4121.x
SP  - 126
EP  - 204
PY  - 2004
ER  - 

AU  - Dolak, Terence M.
AU  - Lever Jr., O. William
AU  - Marsh, David
AU  - Moran, Irene
AU  - Sutton, Scott
TI  - Ophthalmological Preparations
SN  - 9783527303854
UR  - https://doi.org/10.1002/14356007.a18_127
DO  - doi:10.1002/14356007.a18_127
PY  - 2004
AB  - Abstract The article contains sections titled: 1. Introduction 2. Anesthetics 2.1. Topical Anesthetics 2.2. Regional Anesthetics 3. Antimicrobial Agents 3.1. Antibacterial Agents 3.1.1. Sulfonamides 3.1.2. ?-Lactam Antibiotics 3.1.2.1. Penicillins 3.1.2.2. Cephalosporins 3.1.3. Tetracycline Antibiotics 3.1.4. Aminoglycoside Antibiotics 3.1.5. Polypeptide Antibiotics 3.1.6. Miscellaneous Antimicrobial Agents 3.2. Antifungal Agents 3.3. Antiprotozoal Agents 3.4. Antiviral Agents 4. Anti-inflammatory Agents 4.1. Corticosteroids 4.2. Miscellaneous Anti-inflammatory Agents 5. Antiglaucomatous Agents 5.1. Sympathomimetic Drugs 5.2. ?-Adrenergic Blocking Agents 5.3. Carbonic Anhydrase Inhibitors 5.4. Hyperosmotic Agents 5.5. Miotics (Parasympathomimetic Agents) 5.5.1. Cholinergic Agonists 5.5.2. Anticholinesterases 6. Mydriatics and Cycloplegics 6.1. Sympathomimetics 6.2. Parasympatholytics 7. Vasoactive (Adrenergic) Agents 8. Diagnostic Agents 9. Dry Eye Medications 10. Miscellaneous Ophthalmic and Contact Lens Preparations 10.1. Disinfectants and Preservatives 10.1.1. Biguanides 10.1.2. Mercurial Preservatives 10.1.3. Quaternary Ammonium Compounds 10.1.4. Miscellaneous Disinfectants and Preservatives 10.2. Contact Lens Cleaners and Rewetting Agents 10.2.1. Surfactant Cleaners 10.2.2. Enzymatic Cleaners
ER  - 
